“Acute alcohol intoxication”的搜索结果，显示 41-50 项，共有 9796 项

1. 神经科- 临床试验- 妙佑医疗国际

   A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

2. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

3. 症状与病因 - 妙佑医疗国际

   Mild ascites may not cause any symptoms and can be easy to miss. As more fluid builds up and the ascites progresses to moderate or severe, your belly can look ...

4. 肺科- 临床试验- 妙佑医疗国际

   ... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) ...

5. 神经科- 临床试验- 妙佑医疗国际

   A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid ...

7. 心血管医学- 临床试验- 妙佑医疗国际

   The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse width) to the chronic pacing threshold of a pacemaker ...

8. 神经科- 临床试验- 妙佑医疗国际

   A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

9. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

10. 外科 - 临床试验- 妙佑医疗国际

    STAR Trial (Siegel Transcatheter Aortic Valve Replacement In Patients With Symptomatic Severe Aortic Stenosis). Jacksonville, Fla., Rochester, Minn. To evaluate ...